CoChat

Interleukin-1 Blockade in Acute Decompensated Heart Failure: A Randomized, Double-Blinded, Placebo-Controlled Pilot Study

Open access
Van Tassell, Benjamin W., Abouzaki, Nayef A., Oddi Erdle, Claudia, Carbone, Salvatore, Trankle, Cory R., Melchior, Ryan D., Turlington, Jeremy S., Thurber, Clinton J., Christopher, Sanah, Dixon, Dave L., Fronk, Daniel T., Thomas, Christopher S., Rose, Scott W., Buckley, Leo F., Dinarello, Charles A., Biondi-Zoccai, Giuseppe, Abbate, Antonio · 2016 · Journal of Cardiovascular Pharmacology
Cited by 132

The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.

Abstract

BACKGROUND: Heart failure is an inflammatory disease. Patients with acute decompensated heart failure (ADHF) exhibit significant inflammatory activity on admission. We hypothesized that Interleukin-1 blockade, with anakinra (Kineret, Swedish Orphan Biovitrum), would quench the acute inflammatory response in patients with ADHF. METHODS: We randomized 30 patients with ADHF, reduced left ventricular ejection fraction (<40%), and elevated C reactive protein (CRP) levels (≥5 mg/L) to either anakinra 100 mg twice daily for 3 days followed by once daily for 11 days or matching placebo, in a 1:1 double blinded fashion. We measured daily CRP plasma levels using a high-sensitivity assay during hospitalization and then again at 14 days and evaluated the area-under-the-curve and interval changes (delta). RESULTS: Treatment with anakinra was well tolerated. At 72 hours, anakinra reduced CRP by 61% versus baseline, compared with a 6% reduction among patients receiving placebo (P = 0.004 anakinra vs. placebo). CONCLUSIONS: Interleukin-1 blockade with anakinra reduces the systemic inflammatory response in patients with ADHF. Further studies are warranted to determine whether this anti-inflammatory effect translates into improved clinical outcomes.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1097/fjc.0000000000000378

Cites

4 of 4 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cited by

See all 132

Metadata

Authors
Van Tassell, B. W., Abouzaki, N. A., Oddi Erdle, C., Carbone, S., Trankle, C. R., Melchior, R. D., Turlington, J. S., Thurber, C. J., Christopher, S., Dixon, D. L., Fronk, D. T., Thomas, C. S., Rose, S. W., Buckley, L. F., Dinarello, C. A., Biondi-Zoccai, G., & Abbate, A.
Venue
Journal of Cardiovascular Pharmacology
Published
2016-06
Volume
67
Issue
6
Pages
544-551
ISSN
0160-2446 (ISSN-L)
OpenAlex
W2290259186
Cited by
132
References
4
FWCI
9.46
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Interleukin-1 Blockade in Acute Decompensated Heart Failure: A Randomized, Double-Blinded, Placebo-Controlled Pilot Study. https://app.cochat.ai/papers/10.1097/fjc.0000000000000378
The paper
Van Tassell, B. W., Abouzaki, N. A., Oddi Erdle, C., Carbone, S., Trankle, C. R., Melchior, R. D., Turlington, J. S., Thurber, C. J., Christopher, S., Dixon, D. L., Fronk, D. T., Thomas, C. S., Rose, S. W., Buckley, L. F., Dinarello, C. A., Biondi-Zoccai, G., & Abbate, A. (2016). Interleukin-1 Blockade in Acute Decompensated Heart Failure: A Randomized, Double-Blinded, Placebo-Controlled Pilot Study. Journal of Cardiovascular Pharmacology. https://doi.org/10.1097/fjc.0000000000000378

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.